New from CDC
Lower Your Risk for the Number One Killer of Women
Despite an increase in awareness over the past decades, only about half (56%) of women recognize that heart disease is their number 1 killer. Heart disease is the leading cause of death for women in the United States, killing 301,280 women in 2019—or about 1 in every 5 female deaths.
Increases in Pre-pregnancy Obesity: United States, 2016–2019
Pre-pregnancy obesity in the United States rose from 26.1% in 2016 to 29.0% in 2019 and increased steadily for non-Hispanic white, non-Hispanic black, and Hispanic women.
Racial and Ethnic Differences in Women's HIV Risk and Attitudes Towards Pre-exposure Prophylaxis (PrEP) in the Context of the Substance Use, Violence, and Depression Syndemic
Women with syndemic conditions, i.e., two or more co-occurring epidemics, are at elevated risk for HIV acquisition and are therefore prime candidates for pre-exposure prophylaxis (PrEP). However, PrEP uptake remains low among women, especially among Black and Hispanic women.
A Preparedness Model for Mother-Baby Linked Longitudinal Surveillance for Emerging Threats
The Centers for Disease Control and Prevention, in close collaboration with state, local, and territorial health departments, began a 5-year initiative to establish population-based mother-baby linked longitudinal surveillance, the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET).
Rural Disparities in Surgical Care From Gynecologic Oncologists Among Midwestern Ovarian Cancer Patients
Up to one-third of women with ovarian cancer in the United States do not receive surgical care from a gynecologic oncologist specialist despite guideline recommendations. The authors aim to investigate the impact of rurality on receiving surgical care from a specialist, referral to a specialist, and specialist surgery after referral, and the consequences of specialist care.
Sexually Transmitted Infection Testing Among Transgender Women Living with HIV in the United States: Medical Monitoring Project, 2015-2019
National guidelines recommend annual STI testing for sexually active people living with HIV, including transgender women. Using data from the US Medical Monitoring Project during 2015-2019, in the previous 12 months, 63.3% of sexually active HIV-positive transgender women were tested for syphilis, 56.6% for chlamydia, and 54.4% for gonorrhea.
Seasonal Influenza Vaccine in Pregnant Women: Views and Experiences of Obstetrician-Gynecologists
Seasonal influenza vaccination rates among pregnant women remain well below the Healthy People 2020 target of 80%.
National Perinatal Hepatitis B Prevention Program: 2009-2017
Trends and programmatic outcomes among infants born to hepatitis B surface antigen (HBsAg)-positive women from 2009 to 2017 and case-managed by the Centers for Disease Control and Prevention's national Perinatal Hepatitis B Prevention Program (PHBPP).
Assessment of Incidence and Factors Associated With Severe Maternal Morbidity After Delivery Discharge Among Women in the US
Previous efforts to examine severe maternal morbidity (SMM) in the US have focused on delivery hospitalizations. Little is known about de novo SMM that occurs after delivery discharge.
